Nations must start testing and regulating chemicals and chemical products as closely as the current systems that safeguard prescription drugs or risk rising rates of chronic illnesses among children, according to a New England Journal of Medicine report by a group of experts writing as the Consortium for Children’s Environmental Health.
Agios sells rights to glioma drug to Royalty Pharma; Cargo’s $110M placement
Plus, news about Turn Biotechnologies, HanAll Biopharma, Corcept Therapeutics, Actuate and Merck: Agios sells vorasidenib rights to Royalty Pharma: As part of the agreement, the